Under the agreement, VISUfarma will make a strategic investment in Visus, a wholly owned subsidiary of Tenpoint Therapeutics Holding Limited.
iStock
This Site is Intended for Healthcare Professionals Only
Search
AI Powered
Human content,
AI powered search.
Latest Stories
Start your day right!
Get the latest updates and insights delivered to your inbox
Primary hyperhidrosis commonly begins during childhood or adolescence and may persist throughout life.
iStock
A survey by LloydsPharmacy Online Doctor found that it is the lifestyle preferences, rather than health-related motivations, that are increasingly influencing the people towards weight management treatments.
iStock
The MHRA has published a position paper outlining the regulatory framework for microbiome-based medicinal products (MBMPs) in the UK.
iStock
×
Terms and Conditions
By clicking the 'Subscribe’, you agree to receive our newsletter, marketing communications and industry
partners/sponsors sharing promotional product information via email and print communication from Asian Trade
Publications Ltd and subsidiaries. You have the right to withdraw your consent at any time by clicking the
unsubscribe link in our emails. We will use your email address to personalize our communications and send you
relevant offers. Your data will be stored up to 30 days after unsubscribing.
Contact us at
data@amg.biz
to see how we manage and store your data.
×
Terms and Conditions
By clicking the 'Subscribe’, you agree to receive our newsletter, marketing communications and industry
partners/sponsors sharing promotional product information via email and print communication from Asian Trade
Publications Ltd and subsidiaries. You have the right to withdraw your consent at any time by clicking the
unsubscribe link in our emails. We will use your email address to personalize our communications and send you
relevant offers. Your data will be stored up to 30 days after unsubscribing.
Contact us at data@amg.biz to see how we manage and store your data.